trending Market Intelligence /marketintelligence/en/news-insights/trending/8-d1AWCpxacYLGS6hn_7EQ2 content esgSubNav
In This List

Zimmer Biomet's robot-assisted system gets US FDA approval for spine surgeries

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Zimmer Biomet's robot-assisted system gets US FDA approval for spine surgeries

Zimmer Biomet Holdings Inc. said its robot-assisted system Rosa was approved by the U.S. Food and Drug Administration for spine surgeries.

The Rosa spine system received FDA's 510(k) clearance, which authorizes Zimmer to market the device as safe and effective, or substantially equivalent, to a legally marketed device.

Zimmer Biomet's Rosa spine system provides surgeons tools and real-time data that help improve implant procedures and instrument placement accuracy.

The FDA has also approved the Warsaw, Ind.-based medical device-maker's Rosa systems for brain and knee surgeries.